somatrogon-ghla
Drug Details
- Generic Name
- somatrogon-ghla
- Brand Names
- Ngenla
- Application Number
- BLA761184
- Sponsor
- Pfizer Laboratories Div Pfizer Inc
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- SOMATROGON
Indications and Usage
1 INDICATIONS AND USAGE NGENLA is indicated for the treatment of pediatric patients aged 3 years and older who have growth failure due to an inadequate secretion of endogenous growth hormone. NGENLA is a human growth hormone analog indicated for treatment of pediatric patients aged 3 years and older who have growth failure due to inadequate secretion of endogenous growth hormone ( 1 ).